[HTML][HTML] Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectives
HM Vedeld, A Goel, GE Lind - Seminars in cancer biology, 2018 - Elsevier
Abstract Each year, almost 4.1 million people are diagnosed with gastrointestinal (GI)
cancers. Due to late detection of this disease, the mortality is high, causing approximately 3 …
cancers. Due to late detection of this disease, the mortality is high, causing approximately 3 …
Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectives.
HM Vedeld, A Goel, GE Lind - Seminars in Cancer Biology, 2017 - europepmc.org
Abstract Each year, almost 4.1 million people are diagnosed with gastrointestinal (GI)
cancers. Due to late detection of this disease, the mortality is high, causing approximately 3 …
cancers. Due to late detection of this disease, the mortality is high, causing approximately 3 …
[PDF][PDF] Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectives
HM Vedelda, A Goeld, GE Linda - Semin Cancer Biol, 2018 - scienceopen.com
Abstract Each year, almost 4.1 million people are diagnosed with gastrointestinal (GI)
cancers. Due to late detection of this disease, the mortality is high, causing approximately 3 …
cancers. Due to late detection of this disease, the mortality is high, causing approximately 3 …
[引用][C] Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectives
HM Vedeld, A Goel, GE Lind - Seminars in Cancer Biology, 2018 - cir.nii.ac.jp
Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectives |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
[HTML][HTML] Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectives
HM Vedeld, A Goel, GE Lind - Seminars in cancer biology, 2018 - ncbi.nlm.nih.gov
Abstract Each year, almost 4.1 million people are diagnosed with gastrointestinal (GI)
cancers. Due to late detection of this disease, the mortality is high, causing approximately 3 …
cancers. Due to late detection of this disease, the mortality is high, causing approximately 3 …
Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectives
HM Vedeld, A Goel, GE Lind - Seminars in cancer biology, 2018 - pubmed.ncbi.nlm.nih.gov
Each year, almost 4.1 million people are diagnosed with gastrointestinal (GI) cancers. Due
to late detection of this disease, the mortality is high, causing approximately 3 million cancer …
to late detection of this disease, the mortality is high, causing approximately 3 million cancer …
Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectives.
HM Vedeld, A Goel, GE Lind - Seminars in Cancer Biology, 2017 - europepmc.org
Abstract Each year, almost 4.1 million people are diagnosed with gastrointestinal (GI)
cancers. Due to late detection of this disease, the mortality is high, causing approximately 3 …
cancers. Due to late detection of this disease, the mortality is high, causing approximately 3 …